Therapeutic efficacy of pharmacologic ascorbate in combination with targeted and immunotherapy in melanoma

被引：0
|
作者：
Niessner, H. [1 ]
Amaral, T. [1 ]
Burkard, M. [2 ]
Leischner, C. [2 ]
Renner, O. [2 ]
Ploger, S. [1 ]
Meraz-Torres, F. [1 ]
Bocker, M. [1 ]
Hirn, C. [1 ]
Lauer, U. [3 ]
Busch, C. [4 ]
Venturelli, S. [2 ]
Flatz, L. [1 ]
Sinnberg, T. [1 ]
机构：
[1] Univ Tubingen, Dermato Onkol, Tubingen, Germany
[2] Univ Hohenheim, Inst Nutrit Sci, Dept Nutrit Biochem, Hohenheim, Germany
[3] Univ Tubingen, Dept Internal Med 8, Tubingen, Germany
[4] Dermatol Zum Delfin, Winterthur, Switzerland
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2022年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
FV34
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [41] The Promise of Molecularly Targeted and Immunotherapy for Advanced Melanoma
    Kim Margolin
    Current Treatment Options in Oncology, 2016, 17
  • [42] Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma
    Wang, Xue
    Ma, Shanshan
    Zhu, Shuting
    Zhu, Liucun
    Guo, Wenna
    BIOMEDICINES, 2025, 13 (01)
  • [43] Advances in targeted therapy and immunotherapy for melanoma (Review)
    Qin, Ziyao
    Zheng, Mei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (03)
  • [44] Pharmacologic ascorbate opens a therapeutic window for ATM inhibition and radiotherapy in colorectal cancer
    Callaghan, Cameron M.
    Abukhiran, Ibrahim M.
    Van Rheeden, Richard V.
    Kalen, Amanda L.
    Rodman, Samuel N.
    Petronek, Michael S.
    Mapuskar, Kranti A.
    Mott, Sarah L.
    Coleman, Mitchell C.
    Goswami, Prabhat C.
    Buatti, John M.
    Allen, Bryan G.
    Spitz, Douglas R.
    Caster, Joseph M.
    CANCER RESEARCH, 2022, 82 (12)
  • [45] Immunotherapy of melanoma: efficacy and mode of action
    Wieder, Thomas
    Brenner, Ellen
    Braumueller, Heidi
    Roecken, Martin
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (01): : 28 - 36
  • [46] Efficacy of immunotherapy for metastatic mucosal melanoma
    Shreders, Amanda
    Joseph, Richard W.
    IMMUNOTHERAPY, 2016, 8 (08) : 843 - 845
  • [47] Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy
    Kim, Jeongrae
    Choi, Yongwhan
    Kim, Dong-Hwee
    Yoon, Hong Yeol
    Kim, Kwangmeyung
    PHARMACEUTICS, 2022, 14 (09)
  • [48] Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma
    Lamiaux, Marie
    Scalbert, Camille
    Lepesant, Pauline
    Desmedt, Eve
    Templier, Carole
    Dziwniel, Veronique
    Staumont-Salle, Delphine
    Mortier, Laurent
    MELANOMA RESEARCH, 2018, 28 (05) : 451 - 457
  • [49] Potassium Ascorbate with Ribose: Promising Therapeutic Approach for Melanoma Treatment
    Cavicchio, Carlotta
    Benedusi, Mascia
    Pambianchi, Erika
    Pecorelli, Alessandra
    Cervellati, Franco
    Savelli, Vinno
    Calamandrei, Duccio
    Maellaro, Emilia
    Rispoli, Giorgio
    Maioli, Emanuela
    Valacchi, Giuseppe
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [50] NICE approves immunotherapy combination for advanced melanoma
    Wise, Jacqui
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
12345